4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-006562
EVP R&D, Chief Medical Officer gave up 5,452 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 12,278 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-22 | Exercise or conversion : show line 1 in the form | +12,278 | 110,886 | D | ||
| 2024-02-22 | Shares withheld for taxes : show line 2 in the form | −5,452 | $28.91 | $157,617 | 105,434 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-22 | Exercise or conversion : show line 3 in the form Restricted Stock Unit Award | −12,278 | 12,279 | D |
Loading xslF345X05/form4.xml…